nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A5—Estradiol—osteoporosis	0.0603	0.162	CbGbCtD
Nimodipine—CYP3A4—Estropipate—osteoporosis	0.0567	0.152	CbGbCtD
Nimodipine—CYP3A4—Calcitriol—osteoporosis	0.0567	0.152	CbGbCtD
Nimodipine—CYP3A4—Ergocalciferol—osteoporosis	0.0453	0.122	CbGbCtD
Nimodipine—CYP3A4—Raloxifene—osteoporosis	0.0378	0.101	CbGbCtD
Nimodipine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0365	0.0979	CbGbCtD
Nimodipine—CYP3A4—Cholecalciferol—osteoporosis	0.0292	0.0783	CbGbCtD
Nimodipine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0268	0.0719	CbGbCtD
Nimodipine—CYP3A4—Estradiol—osteoporosis	0.0235	0.0631	CbGbCtD
Nimodipine—Immune system disorder—Estropipate—osteoporosis	0.00182	0.00456	CcSEcCtD
Nimodipine—Depression—Ethinyl Estradiol—osteoporosis	0.00182	0.00454	CcSEcCtD
Nimodipine—Cardiac disorder—Raloxifene—osteoporosis	0.00182	0.00454	CcSEcCtD
Nimodipine—Flushing—Raloxifene—osteoporosis	0.00182	0.00454	CcSEcCtD
Nimodipine—Cramp muscle—Zoledronate—osteoporosis	0.0018	0.00451	CcSEcCtD
Nimodipine—Cardiac disorder—Ibandronate—osteoporosis	0.0018	0.00449	CcSEcCtD
Nimodipine—Phlebitis—Estradiol—osteoporosis	0.00179	0.00448	CcSEcCtD
Nimodipine—Pruritus—Calcium Acetate—osteoporosis	0.00179	0.00447	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Estradiol—osteoporosis	0.00178	0.00443	CcSEcCtD
Nimodipine—Angiopathy—Raloxifene—osteoporosis	0.00178	0.00443	CcSEcCtD
Nimodipine—Depression—Risedronate—osteoporosis	0.00177	0.00443	CcSEcCtD
Nimodipine—Angiopathy—Ibandronate—osteoporosis	0.00176	0.00439	CcSEcCtD
Nimodipine—Immune system disorder—Ibandronate—osteoporosis	0.00175	0.00437	CcSEcCtD
Nimodipine—Cramp muscle—Conjugated Estrogens—osteoporosis	0.00174	0.00434	CcSEcCtD
Nimodipine—Diarrhoea—Calcium Acetate—osteoporosis	0.00173	0.00432	CcSEcCtD
Nimodipine—Muscle spasms—Estropipate—osteoporosis	0.00169	0.00422	CcSEcCtD
Nimodipine—Sweating increased—Zoledronate—osteoporosis	0.00169	0.00421	CcSEcCtD
Nimodipine—Hepatobiliary disease—Risedronate—osteoporosis	0.00168	0.0042	CcSEcCtD
Nimodipine—Dizziness—Calcium Acetate—osteoporosis	0.00167	0.00417	CcSEcCtD
Nimodipine—Muscle spasms—Alendronate—osteoporosis	0.00167	0.00416	CcSEcCtD
Nimodipine—Muscle spasms—Raloxifene—osteoporosis	0.00164	0.00409	CcSEcCtD
Nimodipine—Sweating increased—Conjugated Estrogens—osteoporosis	0.00162	0.00406	CcSEcCtD
Nimodipine—Muscle spasms—Ibandronate—osteoporosis	0.00162	0.00405	CcSEcCtD
Nimodipine—Vomiting—Calcium Acetate—osteoporosis	0.00161	0.00401	CcSEcCtD
Nimodipine—Anaemia—Alendronate—osteoporosis	0.0016	0.004	CcSEcCtD
Nimodipine—Anaemia—Ibandronate—osteoporosis	0.00156	0.00389	CcSEcCtD
Nimodipine—Palpitations—Estropipate—osteoporosis	0.00155	0.00388	CcSEcCtD
Nimodipine—Depression—Zoledronate—osteoporosis	0.00154	0.00385	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00151	0.00377	CcSEcCtD
Nimodipine—Nausea—Calcium Acetate—osteoporosis	0.0015	0.00375	CcSEcCtD
Nimodipine—Myalgia—Estropipate—osteoporosis	0.0015	0.00374	CcSEcCtD
Nimodipine—Palpitations—Ibandronate—osteoporosis	0.00149	0.00372	CcSEcCtD
Nimodipine—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00149	0.00371	CcSEcCtD
Nimodipine—Depression—Conjugated Estrogens—osteoporosis	0.00148	0.0037	CcSEcCtD
Nimodipine—Cardiac disorder—Risedronate—osteoporosis	0.00148	0.0037	CcSEcCtD
Nimodipine—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00148	0.00369	CcSEcCtD
Nimodipine—Myalgia—Alendronate—osteoporosis	0.00147	0.00368	CcSEcCtD
Nimodipine—Hypertension—Ibandronate—osteoporosis	0.00146	0.00364	CcSEcCtD
Nimodipine—Myalgia—Raloxifene—osteoporosis	0.00145	0.00362	CcSEcCtD
Nimodipine—Angiopathy—Risedronate—osteoporosis	0.00145	0.00362	CcSEcCtD
Nimodipine—Immune system disorder—Risedronate—osteoporosis	0.00144	0.0036	CcSEcCtD
Nimodipine—Myalgia—Ibandronate—osteoporosis	0.00144	0.00359	CcSEcCtD
Nimodipine—Oedema—Estropipate—osteoporosis	0.00144	0.00358	CcSEcCtD
Nimodipine—Liver function test abnormal—Estradiol—osteoporosis	0.00143	0.00356	CcSEcCtD
Nimodipine—Hypertension—Calcitriol—osteoporosis	0.00143	0.00356	CcSEcCtD
Nimodipine—Bradycardia—Zoledronate—osteoporosis	0.00141	0.00352	CcSEcCtD
Nimodipine—Flushing—Pamidronate—osteoporosis	0.00141	0.00352	CcSEcCtD
Nimodipine—Cardiac disorder—Pamidronate—osteoporosis	0.00141	0.00352	CcSEcCtD
Nimodipine—Nervous system disorder—Estropipate—osteoporosis	0.00141	0.00352	CcSEcCtD
Nimodipine—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.00141	0.00351	CcSEcCtD
Nimodipine—Myalgia—Calcitriol—osteoporosis	0.00141	0.00351	CcSEcCtD
Nimodipine—Cramp muscle—Estradiol—osteoporosis	0.00139	0.00347	CcSEcCtD
Nimodipine—Angiopathy—Pamidronate—osteoporosis	0.00138	0.00344	CcSEcCtD
Nimodipine—Immune system disorder—Pamidronate—osteoporosis	0.00137	0.00342	CcSEcCtD
Nimodipine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00137	0.00342	CcSEcCtD
Nimodipine—Nervous system disorder—Raloxifene—osteoporosis	0.00136	0.0034	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Estradiol—osteoporosis	0.00136	0.0034	CcSEcCtD
Nimodipine—Thrombocytopenia—Raloxifene—osteoporosis	0.00136	0.0034	CcSEcCtD
Nimodipine—Nervous system disorder—Ibandronate—osteoporosis	0.00135	0.00337	CcSEcCtD
Nimodipine—Hyperhidrosis—Raloxifene—osteoporosis	0.00134	0.00336	CcSEcCtD
Nimodipine—Muscle spasms—Risedronate—osteoporosis	0.00134	0.00334	CcSEcCtD
Nimodipine—Hyperhidrosis—Ibandronate—osteoporosis	0.00133	0.00332	CcSEcCtD
Nimodipine—Nausea—Ergocalciferol—osteoporosis	0.00133	0.00331	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00131	0.00327	CcSEcCtD
Nimodipine—Sweating increased—Estradiol—osteoporosis	0.0013	0.00325	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00129	0.00322	CcSEcCtD
Nimodipine—Cardiac disorder—Zoledronate—osteoporosis	0.00129	0.00321	CcSEcCtD
Nimodipine—Flushing—Zoledronate—osteoporosis	0.00129	0.00321	CcSEcCtD
Nimodipine—Anaemia—Risedronate—osteoporosis	0.00128	0.00321	CcSEcCtD
Nimodipine—Muscle spasms—Pamidronate—osteoporosis	0.00127	0.00317	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00127	0.00316	CcSEcCtD
Nimodipine—Angiopathy—Zoledronate—osteoporosis	0.00126	0.00314	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00125	0.00313	CcSEcCtD
Nimodipine—Immune system disorder—Zoledronate—osteoporosis	0.00125	0.00313	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00124	0.00309	CcSEcCtD
Nimodipine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00124	0.00309	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00123	0.00307	CcSEcCtD
Nimodipine—Hypersensitivity—Etidronic acid—osteoporosis	0.00122	0.00305	CcSEcCtD
Nimodipine—Anaemia—Pamidronate—osteoporosis	0.00122	0.00305	CcSEcCtD
Nimodipine—Angiopathy—Conjugated Estrogens—osteoporosis	0.00121	0.00302	CcSEcCtD
Nimodipine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00121	0.00301	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.0012	0.003	CcSEcCtD
Nimodipine—Hypertension—Risedronate—osteoporosis	0.0012	0.003	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00119	0.00297	CcSEcCtD
Nimodipine—Depression—Estradiol—osteoporosis	0.00119	0.00296	CcSEcCtD
Nimodipine—Myalgia—Risedronate—osteoporosis	0.00118	0.00295	CcSEcCtD
Nimodipine—Pruritus—Etidronic acid—osteoporosis	0.00117	0.00293	CcSEcCtD
Nimodipine—Oedema—Ethinyl Estradiol—osteoporosis	0.00116	0.00291	CcSEcCtD
Nimodipine—Muscle spasms—Zoledronate—osteoporosis	0.00116	0.0029	CcSEcCtD
Nimodipine—Jaundice—Estradiol—osteoporosis	0.00116	0.0029	CcSEcCtD
Nimodipine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00114	0.00285	CcSEcCtD
Nimodipine—Hypertension—Pamidronate—osteoporosis	0.00114	0.00285	CcSEcCtD
Nimodipine—Diarrhoea—Etidronic acid—osteoporosis	0.00114	0.00283	CcSEcCtD
Nimodipine—Hepatobiliary disease—Estradiol—osteoporosis	0.00113	0.00281	CcSEcCtD
Nimodipine—Myalgia—Pamidronate—osteoporosis	0.00112	0.00281	CcSEcCtD
Nimodipine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00112	0.00279	CcSEcCtD
Nimodipine—Anaemia—Zoledronate—osteoporosis	0.00112	0.00279	CcSEcCtD
Nimodipine—Nervous system disorder—Risedronate—osteoporosis	0.00111	0.00278	CcSEcCtD
Nimodipine—Oedema—Pamidronate—osteoporosis	0.00108	0.00269	CcSEcCtD
Nimodipine—Hepatitis—Estradiol—osteoporosis	0.00107	0.00267	CcSEcCtD
Nimodipine—Palpitations—Zoledronate—osteoporosis	0.00107	0.00266	CcSEcCtD
Nimodipine—Hypersensitivity—Estropipate—osteoporosis	0.00106	0.00264	CcSEcCtD
Nimodipine—Nervous system disorder—Pamidronate—osteoporosis	0.00106	0.00264	CcSEcCtD
Nimodipine—Thrombocytopenia—Pamidronate—osteoporosis	0.00106	0.00264	CcSEcCtD
Nimodipine—Vomiting—Etidronic acid—osteoporosis	0.00105	0.00263	CcSEcCtD
Nimodipine—Tachycardia—Pamidronate—osteoporosis	0.00105	0.00263	CcSEcCtD
Nimodipine—Rash—Etidronic acid—osteoporosis	0.00105	0.00261	CcSEcCtD
Nimodipine—Dermatitis—Etidronic acid—osteoporosis	0.00105	0.00261	CcSEcCtD
Nimodipine—Hyperhidrosis—Pamidronate—osteoporosis	0.00104	0.0026	CcSEcCtD
Nimodipine—Hypertension—Zoledronate—osteoporosis	0.00104	0.0026	CcSEcCtD
Nimodipine—Hypersensitivity—Alendronate—osteoporosis	0.00104	0.0026	CcSEcCtD
Nimodipine—Headache—Etidronic acid—osteoporosis	0.00104	0.0026	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00103	0.00258	CcSEcCtD
Nimodipine—Myalgia—Zoledronate—osteoporosis	0.00103	0.00257	CcSEcCtD
Nimodipine—Palpitations—Conjugated Estrogens—osteoporosis	0.00103	0.00256	CcSEcCtD
Nimodipine—Pruritus—Estropipate—osteoporosis	0.00102	0.00254	CcSEcCtD
Nimodipine—Hypersensitivity—Ibandronate—osteoporosis	0.00101	0.00253	CcSEcCtD
Nimodipine—Dyspnoea—Risedronate—osteoporosis	0.00101	0.00253	CcSEcCtD
Nimodipine—Hypotension—Pamidronate—osteoporosis	0.00101	0.00252	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.001	0.00251	CcSEcCtD
Nimodipine—Pruritus—Alendronate—osteoporosis	0.001	0.0025	CcSEcCtD
Nimodipine—Hypersensitivity—Calcitriol—osteoporosis	0.000993	0.00248	CcSEcCtD
Nimodipine—Flushing—Estradiol—osteoporosis	0.000992	0.00248	CcSEcCtD
Nimodipine—Cardiac disorder—Estradiol—osteoporosis	0.000992	0.00248	CcSEcCtD
Nimodipine—Myalgia—Conjugated Estrogens—osteoporosis	0.000989	0.00247	CcSEcCtD
Nimodipine—Nausea—Etidronic acid—osteoporosis	0.000985	0.00246	CcSEcCtD
Nimodipine—Oedema—Zoledronate—osteoporosis	0.000985	0.00246	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000982	0.00245	CcSEcCtD
Nimodipine—Diarrhoea—Estropipate—osteoporosis	0.000982	0.00245	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000979	0.00245	CcSEcCtD
Nimodipine—Pruritus—Ibandronate—osteoporosis	0.000974	0.00243	CcSEcCtD
Nimodipine—Angiopathy—Estradiol—osteoporosis	0.000969	0.00242	CcSEcCtD
Nimodipine—Diarrhoea—Alendronate—osteoporosis	0.000967	0.00242	CcSEcCtD
Nimodipine—Nervous system disorder—Zoledronate—osteoporosis	0.000966	0.00241	CcSEcCtD
Nimodipine—Immune system disorder—Estradiol—osteoporosis	0.000965	0.00241	CcSEcCtD
Nimodipine—Thrombocytopenia—Zoledronate—osteoporosis	0.000964	0.00241	CcSEcCtD
Nimodipine—Dyspnoea—Pamidronate—osteoporosis	0.000961	0.0024	CcSEcCtD
Nimodipine—Tachycardia—Zoledronate—osteoporosis	0.000961	0.0024	CcSEcCtD
Nimodipine—Pruritus—Calcitriol—osteoporosis	0.000953	0.00238	CcSEcCtD
Nimodipine—Hyperhidrosis—Zoledronate—osteoporosis	0.000952	0.00238	CcSEcCtD
Nimodipine—Diarrhoea—Raloxifene—osteoporosis	0.000951	0.00238	CcSEcCtD
Nimodipine—Dizziness—Estropipate—osteoporosis	0.000949	0.00237	CcSEcCtD
Nimodipine—Oedema—Conjugated Estrogens—osteoporosis	0.000948	0.00237	CcSEcCtD
Nimodipine—Diarrhoea—Ibandronate—osteoporosis	0.000942	0.00235	CcSEcCtD
Nimodipine—Dizziness—Alendronate—osteoporosis	0.000935	0.00233	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000931	0.00232	CcSEcCtD
Nimodipine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00093	0.00232	CcSEcCtD
Nimodipine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000926	0.00231	CcSEcCtD
Nimodipine—Diarrhoea—Calcitriol—osteoporosis	0.000922	0.0023	CcSEcCtD
Nimodipine—Hypotension—Zoledronate—osteoporosis	0.00092	0.0023	CcSEcCtD
Nimodipine—Dizziness—Raloxifene—osteoporosis	0.000919	0.0023	CcSEcCtD
Nimodipine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000917	0.00229	CcSEcCtD
Nimodipine—Vomiting—Estropipate—osteoporosis	0.000913	0.00228	CcSEcCtD
Nimodipine—Dizziness—Ibandronate—osteoporosis	0.00091	0.00227	CcSEcCtD
Nimodipine—Rash—Estropipate—osteoporosis	0.000905	0.00226	CcSEcCtD
Nimodipine—Dermatitis—Estropipate—osteoporosis	0.000904	0.00226	CcSEcCtD
Nimodipine—Headache—Estropipate—osteoporosis	0.000899	0.00225	CcSEcCtD
Nimodipine—Vomiting—Alendronate—osteoporosis	0.000899	0.00224	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000897	0.00224	CcSEcCtD
Nimodipine—Muscle spasms—Estradiol—osteoporosis	0.000894	0.00223	CcSEcCtD
Nimodipine—Rash—Alendronate—osteoporosis	0.000891	0.00223	CcSEcCtD
Nimodipine—Dermatitis—Alendronate—osteoporosis	0.000891	0.00222	CcSEcCtD
Nimodipine—Hypotension—Conjugated Estrogens—osteoporosis	0.000886	0.00221	CcSEcCtD
Nimodipine—Headache—Alendronate—osteoporosis	0.000886	0.00221	CcSEcCtD
Nimodipine—Vomiting—Raloxifene—osteoporosis	0.000884	0.00221	CcSEcCtD
Nimodipine—Dyspnoea—Zoledronate—osteoporosis	0.000878	0.00219	CcSEcCtD
Nimodipine—Rash—Raloxifene—osteoporosis	0.000877	0.00219	CcSEcCtD
Nimodipine—Dermatitis—Raloxifene—osteoporosis	0.000876	0.00219	CcSEcCtD
Nimodipine—Vomiting—Ibandronate—osteoporosis	0.000875	0.00219	CcSEcCtD
Nimodipine—Headache—Raloxifene—osteoporosis	0.000871	0.00218	CcSEcCtD
Nimodipine—Rash—Ibandronate—osteoporosis	0.000868	0.00217	CcSEcCtD
Nimodipine—Dermatitis—Ibandronate—osteoporosis	0.000867	0.00217	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000864	0.00216	CcSEcCtD
Nimodipine—Headache—Ibandronate—osteoporosis	0.000862	0.00215	CcSEcCtD
Nimodipine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000857	0.00214	CcSEcCtD
Nimodipine—Vomiting—Calcitriol—osteoporosis	0.000857	0.00214	CcSEcCtD
Nimodipine—Nausea—Estropipate—osteoporosis	0.000853	0.00213	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00085	0.00212	CcSEcCtD
Nimodipine—Rash—Calcitriol—osteoporosis	0.00085	0.00212	CcSEcCtD
Nimodipine—Dermatitis—Calcitriol—osteoporosis	0.000849	0.00212	CcSEcCtD
Nimodipine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000846	0.00211	CcSEcCtD
Nimodipine—Headache—Calcitriol—osteoporosis	0.000844	0.00211	CcSEcCtD
Nimodipine—Nausea—Alendronate—osteoporosis	0.00084	0.0021	CcSEcCtD
Nimodipine—Hypersensitivity—Risedronate—osteoporosis	0.000836	0.00209	CcSEcCtD
Nimodipine—Nausea—Raloxifene—osteoporosis	0.000826	0.00206	CcSEcCtD
Nimodipine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000823	0.00206	CcSEcCtD
Nimodipine—Palpitations—Estradiol—osteoporosis	0.000822	0.00205	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000819	0.00204	CcSEcCtD
Nimodipine—Nausea—Ibandronate—osteoporosis	0.000818	0.00204	CcSEcCtD
Nimodipine—Hypertension—Estradiol—osteoporosis	0.000803	0.00201	CcSEcCtD
Nimodipine—Pruritus—Risedronate—osteoporosis	0.000803	0.002	CcSEcCtD
Nimodipine—Nausea—Calcitriol—osteoporosis	0.0008	0.002	CcSEcCtD
Nimodipine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000796	0.00199	CcSEcCtD
Nimodipine—Hypersensitivity—Pamidronate—osteoporosis	0.000794	0.00198	CcSEcCtD
Nimodipine—Myalgia—Estradiol—osteoporosis	0.000792	0.00198	CcSEcCtD
Nimodipine—Diarrhoea—Risedronate—osteoporosis	0.000776	0.00194	CcSEcCtD
Nimodipine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000769	0.00192	CcSEcCtD
Nimodipine—Pruritus—Pamidronate—osteoporosis	0.000763	0.00191	CcSEcCtD
Nimodipine—Oedema—Estradiol—osteoporosis	0.000759	0.0019	CcSEcCtD
Nimodipine—Dizziness—Risedronate—osteoporosis	0.00075	0.00187	CcSEcCtD
Nimodipine—Nervous system disorder—Estradiol—osteoporosis	0.000744	0.00186	CcSEcCtD
Nimodipine—Tachycardia—Estradiol—osteoporosis	0.000741	0.00185	CcSEcCtD
Nimodipine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00074	0.00185	CcSEcCtD
Nimodipine—Diarrhoea—Pamidronate—osteoporosis	0.000738	0.00184	CcSEcCtD
Nimodipine—Hyperhidrosis—Estradiol—osteoporosis	0.000734	0.00183	CcSEcCtD
Nimodipine—Rash—Ethinyl Estradiol—osteoporosis	0.000734	0.00183	CcSEcCtD
Nimodipine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000733	0.00183	CcSEcCtD
Nimodipine—Headache—Ethinyl Estradiol—osteoporosis	0.000729	0.00182	CcSEcCtD
Nimodipine—Hypersensitivity—Zoledronate—osteoporosis	0.000726	0.00181	CcSEcCtD
Nimodipine—Vomiting—Risedronate—osteoporosis	0.000721	0.0018	CcSEcCtD
Nimodipine—Rash—Risedronate—osteoporosis	0.000715	0.00179	CcSEcCtD
Nimodipine—Dermatitis—Risedronate—osteoporosis	0.000715	0.00178	CcSEcCtD
Nimodipine—Dizziness—Pamidronate—osteoporosis	0.000713	0.00178	CcSEcCtD
Nimodipine—Headache—Risedronate—osteoporosis	0.000711	0.00177	CcSEcCtD
Nimodipine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000699	0.00174	CcSEcCtD
Nimodipine—Pruritus—Zoledronate—osteoporosis	0.000697	0.00174	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000692	0.00173	CcSEcCtD
Nimodipine—Nausea—Ethinyl Estradiol—osteoporosis	0.000691	0.00173	CcSEcCtD
Nimodipine—Vomiting—Pamidronate—osteoporosis	0.000686	0.00171	CcSEcCtD
Nimodipine—Rash—Pamidronate—osteoporosis	0.00068	0.0017	CcSEcCtD
Nimodipine—Dermatitis—Pamidronate—osteoporosis	0.000679	0.0017	CcSEcCtD
Nimodipine—Dyspnoea—Estradiol—osteoporosis	0.000677	0.00169	CcSEcCtD
Nimodipine—Headache—Pamidronate—osteoporosis	0.000676	0.00169	CcSEcCtD
Nimodipine—Diarrhoea—Zoledronate—osteoporosis	0.000674	0.00168	CcSEcCtD
Nimodipine—Nausea—Risedronate—osteoporosis	0.000674	0.00168	CcSEcCtD
Nimodipine—Pruritus—Conjugated Estrogens—osteoporosis	0.000671	0.00168	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000655	0.00164	CcSEcCtD
Nimodipine—Dizziness—Zoledronate—osteoporosis	0.000651	0.00163	CcSEcCtD
Nimodipine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000649	0.00162	CcSEcCtD
Nimodipine—Nausea—Pamidronate—osteoporosis	0.00064	0.0016	CcSEcCtD
Nimodipine—Dizziness—Conjugated Estrogens—osteoporosis	0.000627	0.00157	CcSEcCtD
Nimodipine—Vomiting—Zoledronate—osteoporosis	0.000626	0.00156	CcSEcCtD
Nimodipine—Rash—Zoledronate—osteoporosis	0.000621	0.00155	CcSEcCtD
Nimodipine—Dermatitis—Zoledronate—osteoporosis	0.00062	0.00155	CcSEcCtD
Nimodipine—Headache—Zoledronate—osteoporosis	0.000617	0.00154	CcSEcCtD
Nimodipine—Vomiting—Conjugated Estrogens—osteoporosis	0.000603	0.00151	CcSEcCtD
Nimodipine—Rash—Conjugated Estrogens—osteoporosis	0.000598	0.00149	CcSEcCtD
Nimodipine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000597	0.00149	CcSEcCtD
Nimodipine—Headache—Conjugated Estrogens—osteoporosis	0.000594	0.00148	CcSEcCtD
Nimodipine—Nausea—Zoledronate—osteoporosis	0.000585	0.00146	CcSEcCtD
Nimodipine—Nausea—Conjugated Estrogens—osteoporosis	0.000563	0.00141	CcSEcCtD
Nimodipine—Hypersensitivity—Estradiol—osteoporosis	0.000559	0.0014	CcSEcCtD
Nimodipine—Pruritus—Estradiol—osteoporosis	0.000537	0.00134	CcSEcCtD
Nimodipine—Diarrhoea—Estradiol—osteoporosis	0.000519	0.0013	CcSEcCtD
Nimodipine—Dizziness—Estradiol—osteoporosis	0.000502	0.00125	CcSEcCtD
Nimodipine—Vomiting—Estradiol—osteoporosis	0.000483	0.00121	CcSEcCtD
Nimodipine—Rash—Estradiol—osteoporosis	0.000479	0.0012	CcSEcCtD
Nimodipine—Dermatitis—Estradiol—osteoporosis	0.000478	0.00119	CcSEcCtD
Nimodipine—Headache—Estradiol—osteoporosis	0.000476	0.00119	CcSEcCtD
Nimodipine—CACNB3—Metabolism—PNP—osteoporosis	0.000454	0.002	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ATIC—osteoporosis	0.000454	0.002	CbGpPWpGaD
Nimodipine—Nausea—Estradiol—osteoporosis	0.000451	0.00113	CcSEcCtD
Nimodipine—CACNB2—Developmental Biology—ACTG1—osteoporosis	0.000449	0.00198	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL1B—osteoporosis	0.000448	0.00197	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—IL1B—osteoporosis	0.000444	0.00196	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MYC—osteoporosis	0.000438	0.00193	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TLN1—osteoporosis	0.000431	0.0019	CbGpPWpGaD
Nimodipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	0.00043	0.0019	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000427	0.00188	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ACTG1—osteoporosis	0.000426	0.00188	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000422	0.00186	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—ESR2—osteoporosis	0.000417	0.00184	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000409	0.0018	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—WNT1—osteoporosis	0.000408	0.0018	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—IL6R—osteoporosis	0.000408	0.0018	CbGpPWpGaD
Nimodipine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000403	0.00177	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TNF—osteoporosis	0.000397	0.00175	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000396	0.00174	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000391	0.00173	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.00039	0.00172	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—IL1B—osteoporosis	0.00039	0.00172	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—RPL24—osteoporosis	0.00039	0.00172	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—OXCT1—osteoporosis	0.000386	0.0017	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CA2—osteoporosis	0.000386	0.0017	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TLN1—osteoporosis	0.000379	0.00167	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MGLL—osteoporosis	0.000376	0.00166	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ACTG1—osteoporosis	0.000374	0.00165	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IL6—osteoporosis	0.000371	0.00164	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.000361	0.00159	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—WNT1—osteoporosis	0.00035	0.00154	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—LEP—osteoporosis	0.000348	0.00153	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000346	0.00153	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—WNT1—osteoporosis	0.000332	0.00146	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—VDR—osteoporosis	0.000331	0.00146	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—IL6R—osteoporosis	0.000326	0.00144	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TNF—osteoporosis	0.000322	0.00142	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—IDH2—osteoporosis	0.00032	0.00141	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—FDPS—osteoporosis	0.00032	0.00141	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PKM—osteoporosis	0.00032	0.00141	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—IL6R—osteoporosis	0.000317	0.0014	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—ADCY5—osteoporosis	0.000313	0.00138	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.00031	0.00137	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000309	0.00136	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PGLS—osteoporosis	0.000303	0.00134	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPD2—osteoporosis	0.000303	0.00134	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PKM—osteoporosis	0.000303	0.00134	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—FDPS—osteoporosis	0.000303	0.00134	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP27A1—osteoporosis	0.000301	0.00133	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.000293	0.00129	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ACP5—osteoporosis	0.000293	0.00129	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—WNT1—osteoporosis	0.000291	0.00128	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6R—osteoporosis	0.000291	0.00128	CbGpPWpGaD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00029	0.00128	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPD2—osteoporosis	0.000287	0.00127	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PGLS—osteoporosis	0.000287	0.00127	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TNF—osteoporosis	0.000283	0.00125	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—LEP—osteoporosis	0.000278	0.00123	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000278	0.00122	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PNP—osteoporosis	0.000277	0.00122	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ATIC—osteoporosis	0.000277	0.00122	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TPI1—osteoporosis	0.000272	0.0012	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—LEP—osteoporosis	0.00027	0.00119	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PKM—osteoporosis	0.000266	0.00117	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—FDPS—osteoporosis	0.000266	0.00117	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ATIC—osteoporosis	0.000263	0.00116	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PNP—osteoporosis	0.000263	0.00116	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000262	0.00116	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—IL6—osteoporosis	0.000262	0.00116	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.000258	0.00114	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—P4HB—osteoporosis	0.000256	0.00113	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—ESR1—osteoporosis	0.000253	0.00112	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PGLS—osteoporosis	0.000252	0.00111	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPD2—osteoporosis	0.000252	0.00111	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GAPDH—osteoporosis	0.000251	0.00111	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—RAP1A—osteoporosis	0.000245	0.00108	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—OXCT1—osteoporosis	0.000236	0.00104	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CA2—osteoporosis	0.000236	0.00104	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000235	0.00104	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6R—osteoporosis	0.000233	0.00103	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6R—osteoporosis	0.000233	0.00103	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ATIC—osteoporosis	0.000231	0.00102	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PNP—osteoporosis	0.000231	0.00102	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MGLL—osteoporosis	0.00023	0.00101	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6R—osteoporosis	0.000227	0.000999	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PSMA5—osteoporosis	0.000225	0.000991	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PSMA2—osteoporosis	0.000225	0.000991	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000224	0.000989	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CA2—osteoporosis	0.000223	0.000985	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—OXCT1—osteoporosis	0.000223	0.000985	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000221	0.000976	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MGLL—osteoporosis	0.000218	0.00096	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	0.000208	0.000916	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	0.000205	0.000904	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ESR2—osteoporosis	0.000201	0.000886	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6R—osteoporosis	0.000199	0.000879	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—LEP—osteoporosis	0.000198	0.000873	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ENO1—osteoporosis	0.000198	0.000871	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—OXCT1—osteoporosis	0.000196	0.000865	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA2—osteoporosis	0.000196	0.000865	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—IDH2—osteoporosis	0.000195	0.000862	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PSMA2—osteoporosis	0.000195	0.000859	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PSMA5—osteoporosis	0.000195	0.000859	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MGLL—osteoporosis	0.000191	0.000843	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6R—osteoporosis	0.000189	0.000832	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—IDH2—osteoporosis	0.000185	0.000816	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000184	0.000811	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP27A1—osteoporosis	0.000184	0.00081	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000182	0.000802	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—IL6—osteoporosis	0.000182	0.000802	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000181	0.0008	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ACP5—osteoporosis	0.000179	0.000788	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP27A1—osteoporosis	0.000174	0.000767	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TGFB1—osteoporosis	0.000172	0.000759	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—LEP—osteoporosis	0.00017	0.000748	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ACP5—osteoporosis	0.000169	0.000746	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TPI1—osteoporosis	0.000166	0.000733	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6R—osteoporosis	0.000166	0.000732	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6R—osteoporosis	0.000166	0.000731	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—IDH2—osteoporosis	0.000163	0.000717	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—osteoporosis	0.000161	0.000709	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—LEP—osteoporosis	0.000161	0.000709	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—VDR—osteoporosis	0.000159	0.000703	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP19A1—osteoporosis	0.000158	0.000697	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TPI1—osteoporosis	0.000157	0.000694	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—P4HB—osteoporosis	0.000156	0.000689	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GAPDH—osteoporosis	0.000153	0.000676	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP27A1—osteoporosis	0.000153	0.000674	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—RAP1A—osteoporosis	0.000149	0.000658	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ACP5—osteoporosis	0.000149	0.000656	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—P4HB—osteoporosis	0.000148	0.000652	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—IL6—osteoporosis	0.000145	0.000641	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GAPDH—osteoporosis	0.000145	0.00064	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6R—osteoporosis	0.000142	0.000627	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—RAP1A—osteoporosis	0.000141	0.000624	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—IL6—osteoporosis	0.000141	0.000623	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—LEP—osteoporosis	0.000141	0.000623	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TPI1—osteoporosis	0.000138	0.00061	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TGFB1—osteoporosis	0.000138	0.000607	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000135	0.000595	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6R—osteoporosis	0.000135	0.000594	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TGFB1—osteoporosis	0.000134	0.00059	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—osteoporosis	0.000132	0.00058	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—P4HB—osteoporosis	0.00013	0.000573	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6—osteoporosis	0.00013	0.000572	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ADCY5—osteoporosis	0.000129	0.000569	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GPX1—osteoporosis	0.000129	0.000567	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—osteoporosis	0.000129	0.000567	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GAPDH—osteoporosis	0.000128	0.000563	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—osteoporosis	0.000125	0.000551	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—POMC—osteoporosis	0.000125	0.000551	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—RAP1A—osteoporosis	0.000124	0.000548	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ESR1—osteoporosis	0.000122	0.000537	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ENO1—osteoporosis	0.000121	0.000532	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PSMA2—osteoporosis	0.000119	0.000524	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PSMA5—osteoporosis	0.000119	0.000524	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTHFR—osteoporosis	0.000119	0.000523	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6R—osteoporosis	0.000118	0.000522	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FDPS—osteoporosis	0.000118	0.000519	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PKM—osteoporosis	0.000118	0.000519	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ENO1—osteoporosis	0.000114	0.000504	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PSMA2—osteoporosis	0.000113	0.000497	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PSMA5—osteoporosis	0.000113	0.000497	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PGLS—osteoporosis	0.000112	0.000492	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPD2—osteoporosis	0.000112	0.000492	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000109	0.000482	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—osteoporosis	0.000104	0.000457	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—osteoporosis	0.000104	0.000457	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ATIC—osteoporosis	0.000102	0.00045	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PNP—osteoporosis	0.000102	0.00045	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—osteoporosis	0.000101	0.000445	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ENO1—osteoporosis	0.0001	0.000443	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PSMA2—osteoporosis	9.9e-05	0.000436	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PSMA5—osteoporosis	9.9e-05	0.000436	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TGFB1—osteoporosis	9.81e-05	0.000432	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	9.66e-05	0.000426	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP19A1—osteoporosis	9.65e-05	0.000425	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	9.53e-05	0.00042	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—POMC—osteoporosis	9.5e-05	0.000419	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—osteoporosis	9.16e-05	0.000404	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP19A1—osteoporosis	9.14e-05	0.000403	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—osteoporosis	8.88e-05	0.000392	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—OXCT1—osteoporosis	8.69e-05	0.000383	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA2—osteoporosis	8.69e-05	0.000383	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MGLL—osteoporosis	8.47e-05	0.000373	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—osteoporosis	8.41e-05	0.000371	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—osteoporosis	8.41e-05	0.000371	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP19A1—osteoporosis	8.03e-05	0.000354	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—osteoporosis	7.96e-05	0.000351	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ADCY5—osteoporosis	7.89e-05	0.000348	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPX1—osteoporosis	7.86e-05	0.000346	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—osteoporosis	7.85e-05	0.000346	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ADCY5—osteoporosis	7.47e-05	0.000329	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPX1—osteoporosis	7.44e-05	0.000328	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—osteoporosis	7.44e-05	0.000328	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—osteoporosis	7.39e-05	0.000326	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—osteoporosis	7.39e-05	0.000326	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—osteoporosis	7.25e-05	0.00032	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IDH2—osteoporosis	7.2e-05	0.000317	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—osteoporosis	7e-05	0.000309	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—osteoporosis	6.87e-05	0.000303	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP27A1—osteoporosis	6.77e-05	0.000298	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ACP5—osteoporosis	6.58e-05	0.00029	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ADCY5—osteoporosis	6.56e-05	0.000289	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPX1—osteoporosis	6.54e-05	0.000288	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—osteoporosis	6.53e-05	0.000288	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—osteoporosis	6.34e-05	0.000279	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—osteoporosis	6.34e-05	0.000279	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TPI1—osteoporosis	6.12e-05	0.00027	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—osteoporosis	6.04e-05	0.000266	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—osteoporosis	6e-05	0.000265	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—POMC—osteoporosis	5.81e-05	0.000256	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—POMC—osteoporosis	5.8e-05	0.000256	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—P4HB—osteoporosis	5.75e-05	0.000254	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GAPDH—osteoporosis	5.65e-05	0.000249	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RAP1A—osteoporosis	5.5e-05	0.000243	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—POMC—osteoporosis	5.49e-05	0.000242	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PKM—osteoporosis	5.48e-05	0.000241	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FDPS—osteoporosis	5.48e-05	0.000241	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—osteoporosis	5.27e-05	0.000232	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPD2—osteoporosis	5.19e-05	0.000229	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PGLS—osteoporosis	5.19e-05	0.000229	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—POMC—osteoporosis	4.83e-05	0.000213	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ATIC—osteoporosis	4.75e-05	0.000209	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PNP—osteoporosis	4.75e-05	0.000209	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO1—osteoporosis	4.45e-05	0.000196	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSMA2—osteoporosis	4.38e-05	0.000193	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSMA5—osteoporosis	4.38e-05	0.000193	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA2—osteoporosis	4.04e-05	0.000178	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—OXCT1—osteoporosis	4.04e-05	0.000178	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MGLL—osteoporosis	3.94e-05	0.000173	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP19A1—osteoporosis	3.56e-05	0.000157	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH2—osteoporosis	3.35e-05	0.000148	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.15e-05	0.000139	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ACP5—osteoporosis	3.06e-05	0.000135	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ADCY5—osteoporosis	2.9e-05	0.000128	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX1—osteoporosis	2.89e-05	0.000128	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TPI1—osteoporosis	2.85e-05	0.000125	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—P4HB—osteoporosis	2.68e-05	0.000118	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—osteoporosis	2.67e-05	0.000118	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GAPDH—osteoporosis	2.63e-05	0.000116	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RAP1A—osteoporosis	2.56e-05	0.000113	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—POMC—osteoporosis	2.14e-05	9.42e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO1—osteoporosis	2.07e-05	9.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSMA2—osteoporosis	2.04e-05	8.98e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSMA5—osteoporosis	2.04e-05	8.98e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.65e-05	7.29e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADCY5—osteoporosis	1.35e-05	5.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX1—osteoporosis	1.35e-05	5.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—osteoporosis	1.24e-05	5.48e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—POMC—osteoporosis	9.93e-06	4.38e-05	CbGpPWpGaD
